Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
Chicago Style (17. basım) AtıfShehab, Habibul Mohsin, ve Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
MLA (8th ed.) AtıfShehab, Habibul Mohsin, ve Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..